Vieser Jaime 4
4 · Alaunos Therapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
Vieser Jaime
Director
Transactions
- Purchase
Series A-2 Convertible Preferred Stock
2025-06-24$4.49/sh+250$1,123→ 250 totalExercise: $4.49From: 2025-06-24→ Common Stock (55,679.29 underlying)
Footnotes (1)
- [F1]The preferred stock is perpetual and therefore has no expiration date.